Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.0213
-0.0007 (-3.18%)
At close: Mar 20, 2026
Fidia Employees
Fidia had 140 employees as of June 30, 2025.
Employees
140
Change
n/a
Growth
n/a
Revenue / Employee
€150,929
Profits / Employee
€15,657
Market Cap
317.37K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 140 | - | - |
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | - | - |
| Jun 30, 2020 | 289 | -42 | -12.69% |
| Mar 31, 2020 | 299 | -32 | -9.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EuroGroup Laminations | 3,800 |
| Biesse | 3,723 |
| SIT S.p.A. | 1,873 |
| Tesmec | 900 |
| ILPRA | 399 |
| Clabo | 324 |
| Marzocchi Pompe | 263 |
| OSAI Automation System | 249 |
Fidia News
- 10 hours ago - Why Milestone Pharma Stock Is Taking A Dive Today - Benzinga
- 11 hours ago - Children's ibuprofen recall: FDA issues notice for Taro Pharmaceuticals' product - Associated Press
- 11 hours ago - Novo Nordisk Expands Obesity Drug Offerings with FDA Approval - GuruFocus
- 11 hours ago - Palatin's Case Strengthens as Rhythm's FDA Approval Validates Hypothalamic Obesity Market (PTN) - GuruFocus
- 12 hours ago - Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal - Nasdaq
- 12 hours ago - Rhythm Pharma Wins FDA Approval For First-Ever Rare Weight Disorder Therapy - Benzinga
- 13 hours ago - Rhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat' - Investor's Business Daily
- 15 hours ago - Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer - Benzinga